Posted by Michael Wonder on 27 Jun 2019
Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements
27 June 2019 - No new government funds committed to no-deal medicines plans.
The UK pharma industry has made plain its concern and frustration at renewed uncertainty about the risk of a no-deal Brexit, amid often flatly contradictory messages from prime ministerial candidate Boris Johnson.
The UK is currently due to leave the European Union on 31 October, but with outgoing prime minister Theresa May’s withdrawal agreement pronounced ‘dead’ by Boris Johnson and similar sentiments from leadership rival Jeremy Hunt, the risk of a no-deal exit is once again rising.
